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Abstract
The ability to receive standard of care for a diagnosis of infertility is a factor of one’s financial state and educational
level, which are often correlated. Providing infertility care in an under-resourced tertiary care environment provides
challenges but also opportunities for unique successes in creating a family. Among the under-represented populations
are recent immigrants and refugees. Challenges arise when the infertility treatment is futile or when the standard of
care is inaccessible due to cost and scheduling. Unique accomplishments are noted when families are built and hope
is restored for couples fleeing from genocide and war-inflicted countries. This article will highlight two clinical vignettes
from the Division of Reproductive Endocrinology and Infertility clinic at Boston University School of Medicine/Boston
Medical Center. Thereafter, the article will summarize the barriers to care in the United States among those with low
socioeconomic status, with non-dominant racial status (non-Caucasian), and with refugee status. All identifiers have
been removed and names altered in the patient vignettes.
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Patient Vignette 1
Mrs. AL presented to her first Reproductive Endocrin-
ology and Infertility (REI) appointment with her hus-
band. The couple was running late, having taken 3
different buses to arrive. When asked whether they
would like to settle down, have lunch, and return at
1 PM, they replied that they did not have money for
lunch. With a phone interpreter for French Creole, a full
history was elicited. Mrs. AL was approximately 43 years
old. She did not know her exact age but reported that
the women in her family have prolonged fertility into
their 60’s. She had won a lottery for a visa to the United
States. She had a medical history notable for blood-loss
anemia due to uterine leiomyomata. Her uterus was 24-
week sized and extended laterally bilaterally. Magnetic
resonance imaging was notable for multiple leiomyo-
mata. Standard counseling regarding her fibroids, treat-
ment of existing medical conditions, how these
conditions impact fertility, age-related decline in fertility,
the standard work up for infertility, and the basic self-
pay costs for fertility treatments were discussed. In the
intervening two years before she returned for a follow-
up infertility visit, she underwent an open myomectomy
where tubal patency was assessed, and she completed
the basic infertility workup including ovarian function
tests (diminished reserve) and semen analysis (within
normal limits). Through an immersion program, she not
only learned English, but she also obtained a job as a
grocery bagger and saved $2000. Upon returning to
clinic, she stated, “Doctor, I’m going to give you my two
thousand dollars; I want that baby now.” It is apparent
that despite excellent translator services and ample clin-
ical visits, the desire to have children is very strong in
some women and may cloud a true understanding of the
medical complications that are involved. While multiple
counseling visits (each spanning 30–45 min with an in-
terpreter) may be beneficial in promoting health educa-
tion, risk and benefit discussions, and all treatment
options, the self-pay costs per visit may be a deterrent
for patients to return for the clarification they need.
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Further, most of our online and clinical subspecialty re-
sources are in English.
In fact, when counseling this patient on the likelihood
of success and medical futility within her financial pur-
view and comparing that with the most appropriate care
for her history (which was beyond her financial means),
the topic of child-free living was mentioned, and it was
clear that the translator did not have the reproductive
endocrinology and infertility lexicon required to trans-
late this into French/French Creole. The translator inter-
preted “child-free living” as “liberté des enfants” or
“liberation of the child.” The provider intended for this
to be interpreted as living “sans enfants” and was able to
identify the translation error despite not having fluency
in French/French Creole. This patient ultimately under-
went two intrauterine inseminations that were unsuc-
cessful despite counseling on effectiveness and futility.
She subsequently then presented for discussion on
donor egg in vitro fertilization and potential use of a
gestational carrier.
Patient Vignette 2
LN is a 29 year-old woman who presented alone to REI
clinic with a chief complaint of 2 years of infertility des-
pite regular intercourse and monthly menstrual cycles.
The interview was conducted with a phone interpreter
for Amharic. The patient was very nervous and started
crying when asked about family history. She was a refu-
gee from a war-torn country where all her known family
were killed in a genocide. She stated she was an only
child, but it is possible that the fate of her siblings may
have been too difficult to recount. Her medical history
was notable for excision of a cervical lesion. She worked
as a valet attendant locally, and her boyfriend worked as
a valet for a local high-end hotel. She brought cash to
pay for her visit and associated work-up, but she had dif-
ficulty navigating from the accounts receivable office to
the lab for blood draws or to the radiology suite for her
hysterosalpingogram (HSG). She was unable to complete
her labs and HSG for about 3 months, and her partner
was unable to complete a semen analysis due to work
commitments. During her evaluation, she conceived on
a clomiphene citrate challenge test and timed inter-
course. Her pregnancy progressed normally until she de-
veloped preterm severe pre-eclampsia with hemolytic
anemia, elevated liver enzymes, and low platelet count
(HELLP) syndrome. She was delivered by cesarean sec-
tion at 33 weeks gestational age with a viable infant who
was discharged after a stay in the neonatal intensive care
unit. Her post-partum course was complicated by being
found unresponsive in her post-partum bed due to either
a post-ictal state or magnesium toxicity. She was trans-
ferred to the surgical intensive care unit for monitoring
and treatment of labile blood pressures. Her social
support system was notable for presence of friends and
community support. She and her boyfriend were married
and are currently living in a safe environment. She spon-
taneously conceived and is expecting a second child.
While this patient had social support that helped her
through the complications and successful birth, many
other patients presenting here do not and may even face
social stigma for using infertility treatments. In addition,
this patient’s social support system was able help her
with her societal responsibilities, but in many cases pa-
tients who do not have the same support have to request
a quick discharge from the hospital in order to return to
work immediately and keep their jobs.
Background
According to the 2002 National Survey of Family Growth,
7.4 % of married women, or about 2.1 million women, in
the United States were diagnosed with infertility [1]. This
number did not include surveys of women who were not
married or women who were in same sex relationships
who were infertile. Between 2006 and 2010, the National
Survey of Family Growth reported that 14.2 % of women
aged 25–44, or about 5.8 million women, had current in-
fertility problems at the time of the survey. Of this popula-
tion of women aged 25–44 with current infertility
problems, 41 %, or 2.4 million women, had ever used any
infertility services from 2006 and 2010 [2]. However, only
3.1 % of women aged 25–44 with current infertility prob-
lems (179,521 women) used assisted reproductive tech-
nologies (ART) in 2006–2010 [2].
Currently, 15 states offer some form of mandated in-
fertility treatment coverage [3]. However, not everyone
can afford to buy the insurance plans that would help to
ameliorate the cost of infertility treatment. Even with
coverage, the associated cost of ART remains high for
many [2, 4, 5]. Recent literature has revealed that of the
infertile women who are unable to pay for treatments, a
large proportion are non-white and must deal with racial
prejudices, high cost of treatment with low income, lack
of understanding of medical terminology and proce-
dures, and additional cultural expectations and stigmas
[5–9]. Out of the infertile minority patient population in
the United States, refugees and asylum seekers have even
more difficulty accessing infertility care due to even lar-
ger language and cultural barriers, traumatic histories,
and difficulty applying for cost support grants before
they can be approved for permanent United States resi-
dence [10]. The United Nations High Commissioner for
Refugees reports that as of December 2014, 267,222 ref-
ugees and 187,826 asylum seekers are documented in
the United States [11]. It is very difficult to ascertain
how many of this population are of child-bearing poten-
tial because the data is not readily available. However, of
the refugee and asylum arrivals in the United States in
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the 2013 fiscal year, 58.6 % were aged 15–44 [12]. 46.5 %
of the arrivals in 2013 were female [12]. If these percent-
ages are extrapolated to the number of refugees and asy-
lum seekers residing in the United States as of 2014, the
potential child-bearing population is in the hundreds of
thousands. It is important that these patients have access
to infertility evaluation at the very least, as the evalu-
ation may identify general health issues that converge on
fertility. We outline here all the barriers to care that
these populations experience in an effort to bring to
light the need for changes in healthcare.
Costs and coverage of infertility treatment
The American Society of Reproductive Medicine
(ASRM) estimates that the current average cost of an in-
vitro fertilization (IVF) cycle in the United States is
$12,400 [13]. Even with government subsidization, the
cost of an IVF cycle is around 50 % of the annual dispos-
able income in the United States [14]. This is a huge
cost to pay for the hope of having a child, yet of the 50
United States, only fifteen states mandate infertility
treatment coverage. The following eleven states have a
mandate to cover infertility treatments: Arkansas, Con-
necticut, Hawaii, Illinois, Maryland, Massachusetts,
Montana, New Jersey, Ohio, Rhode Island, and West
Virginia [3]. California and Texas have a mandate to
offer the option to buy a health plan that covers infertil-
ity treatments; however, California does not require of-
fering IVF coverage [3]. Louisiana and New York require
that insurance companies cover the treatment of any
correctable medical conditions, which includes some in-
fertility treatments, but not IVF [3].
Under the Massachusetts State Infertility Insurance
Mandate, coverage for infertility treatment is required
from general insurance policies, non-profit hospital ser-
vice corporations, medical service organizations, and
health maintenance organizations that provide fertility-
related benefits [15]. Boston Medical Center is a safety
net hospital that offers underserved populations health-
care coverage under the Boston Medical Center Health-
Net Plan. Safety net hospitals or hospital systems offer
care without question to low-income, uninsured, and
vulnerable populations [16]. HealthNet covers about
220,000 members across MassHealth (Medicaid), Con-
nectorCare, and Qualified Health Plans [17]. However,
under the HealthNet plan, only those customers who
have a Massachusetts Health Connector qualified health
plan, ConnectorCare, a commercial Commonwealth
Choice plan, or health insurance provided by an em-
ployer are covered for infertility treatments [18]. Mas-
sHealth, the Medicaid plan, covers infertility diagnosis
and not treatment [18]. The situation is further compli-
cated by the implementation of the Affordable Care Act,
which mandates that four different plan designs be
offered by health insurance companies that would cover
90, 80, 70, and 60 % of actual medical expenses depend-
ing on the price of the plan purchased [19]. Therefore,
those customers that choose to purchase a health plan
must decide between balancing the costs of an insurance
plan and the anticipated costs of infertility treatments.
Even if a woman of child-bearing age meets the guide-
lines for IVF treatment in a state with mandated cover-
age, she will still need to make hard decisions about her
choice of healthcare insurance, especially since IVF often
needs repeated cycles in order to be successful. A
mandate to cover infertility treatments leads to increased
safer use of IVF, decreased use of riskier treatments, and
higher first birth rates for women over 35 years [11, 17,
20–22]. Despite the demonstrated benefits, many states
have yet to provide their citizens with mandated cover-
age. As a result, there is an unmet demand for infertility
treatments in the United States. In 2003, only 24 % of
the estimated demand for ART was met in North Amer-
ica [14]. The reason for this massive unmet demand, the
highest amongst developed nations [14], may be due to
the many barriers that infertile couples face when con-
sidering ART. Studies have shown that IVF use is closely
associated with higher socioeconomic status [2, 4, 5]
since the economic cost of IVF plays a large role in a
couple’s decision to pursue treatment or not [23].
For refugees, the options are even more limited. Refu-
gees can apply initially for a short-term eight month
maximum health insurance called Refugee Medical As-
sistance, which does not cover the cost of any infertility
treatments [24]. They can also apply for Medicaid or a
safety net program, such as the Health Safety Net in
Massachusetts [24]. However, these safety net programs
only cover the cost of diagnosing infertility. If they are
deemed ineligible for these programs, they will have to
apply for refugee assistance from other sources or buy
insurance independently through the Marketplace [24].
For this population, access to infertility care is a reach,
and access to fertility preservation is an impossibility.
Infertility treatment and race/ethnicity
In addition to financial barriers, there is overwhelming
evidence that there is a huge racial/ethnic disparity
amongst the demographics of patients seeking IVF treat-
ment [5–7]. In a 561 women cohort who presented for
infertility care, Caucasian women comprised a signifi-
cantly larger portion of the women (80.9 %), and the Af-
rican American women (4.5 %) and Hispanic women
(3.9 %) who presented for care were more likely to have
a lower education level and lower income [22]. A study
interviewing 30 infertile Arab American men revealed
that few had the means to pay for ART, even though
many were offered discounts out of sympathy [10]. A
survey of Latino couples, 90 % of whom immigrated
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from a Latin America country and 10 % of whom were
born in the United States, found that none had the eco-
nomic resources to pursue infertility treatment [25]. A co-
hort of immigrant Latinos also reported that cost,
education, communication, difficulty navigating hospital
and insurance systems, and poor physician care prevented
them from accessing infertility treatments [8]. African
American and Hispanic women were less likely than white
women to have money or private insurance to help cover
the costs of infertility treatments [9]. They also reported
having difficulties finding a physician, taking time off of
work, and paying for infertility treatments [26]. In
addition, they pointed to racial/ethnic and social problems
as barriers to care, such as the historic misuse of medical
treatment in their communities and the stigma of infertil-
ity as perceived by friends, family, and their communities
[26]. A study even found that non-white women are less
likely to have insurance that would help to cover the cost
of infertility treatments, further emphasizing the racial/
ethnic disparity [27].
Many of the non-dominant racial/ethnic populations
that struggle with infertility have lower levels of education,
many face cultural barriers such as cultural stigmatization
and fear of disappointing spouses and family, and many
do not speak English [5, 8–10, 22, 25, 26]. To make mat-
ters worse, in 1995, the National Center for Health Statis-
tics found that women who were non-Caucasian and had
lower educational attainment reported infertility more
than women who were Caucasian and had a bachelor’s de-
gree or higher [28].
Though this is an area of developing expertise in re-
search, the vast majority of the literature suggest poorer
ART outcomes in the non-dominant racial populations –
in the United States, the dominant racial population is
Caucasian. In general, African American women tend to
have a longer duration of infertility and higher BMI, re-
quire more aggressive ovarian stimulation, and have a
higher incidence of tubal-factor infertility, uterine-factor
infertility, and leiomyomata; in comparison, white women
tend to have a higher incidence of polycystic ovary syn-
drome, endometriosis, and male-factor infertility [29].
Apart from three studies, the vast majority of the litera-
ture agrees that African American women consistently
have lower success rates after ART. Amongst the outlying
studies on ART outcomes in African American women,
one study found more successful outcomes [30], and two
studies found no significant differences between African
American and Caucasian women [31, 32]. However, the
Nichols et al. [30] and Bendikson et al. [31] studies dealt
with cohorts with a significantly higher percentage of
Caucasian women (91.9 and 91.5 % respectively), and the
study conducted by Dayal et al. [32] was located in
Washington DC, which the authors admitted has a large
percentage of affluent African Americans, meaning that
the socioeconomic factors did not modify the effect esti-
mates as much as they would have in a more disparate
neighborhood.
Fewer studies on ART outcomes in Hispanic women
have been conducted, and a consensus has yet to be
reached. While it has been observed that Hispanic
women have a higher likelihood of having a tubal-factor
infertility diagnosis and non-Hispanic white women have
a higher likelihood of having an endometriosis diagnosis
[33], most studies have found that there are no signifi-
cant differences between the two populations in terms of
birth outcomes, although Hispanic women have gener-
ally demonstrated lower utilization of infertility services
[2, 34, 35].
Studies on ART outcomes in Asian women have been
complicated by the fact that the group is very heteroge-
neous, leading some studies to group all Asian women
regardless of their ethnic background and other studies
to split the women into more specific racial/ethnic cat-
egories resulting in very small cohorts [29]. Asian
women seem to have worse outcomes than Caucasian
women with similar demographic statistics [29]. Re-
searchers have therefore suggested that Asian race may
be an independent risk factor for poor outcome after
ART, although the reason for this is still unclear [36].
Genital tuberculosis, which is rare in most of the world,
is an additional challenge for women who present from
tuberculosis endemic areas such as India [29].
Infertility treatment and refugees
For couples in the United States disadvantaged by low
income and racial/ethnic disparities that hope to get IVF
treatment, there is some hope. Organizations like the
Madeline Gordon Gift of Life Foundation, the Pay It
Forward Fertility Foundation, and the Tinina Q. Cade
Foundation provide grants for couples that qualify as in-
fertile according to the ASRM guidelines and are legal
permanent United States residents. However, refugees
and asylum seekers that have fled to the United States
who struggle with infertility do not qualify for these
hope grants until their application for permanent resi-
dency is approved. This population is only allowed to
apply for residency once a year has passed since they en-
tered the United States, and the duration of the applica-
tion process is unpredictable.
Refugees not only have to deal with normal biological
causes for infertility, but the war and hardship that they
flee from also contribute to their loss of fertility due to
untreated chronic illnesses that many acquire from war
exposures or poor living conditions in refugee camps
[10]. While refugees come from all over the globe, they
universally struggle with chronic illnesses [37], mental
health issues [38], untreated infectious diseases [39],
nutrition-related diseases [40], substance abuse [41], and
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a comorbid combination of any of these conditions [42].
Refugees are further disadvantaged by having less access
to necessary healthcare in their countries of origin that
impact acquired causes of infertility, such as antibiotic
treatments for sexually transmitted infections and cor-
rections of fistulas that occur during and/or after un-
attended childbirth [43]. In addition, refugees may
experience cultural stigma due to receiving infertility
treatments. Only Inhorn and Fakih (2006) [10] have ex-
plored the cultural barriers that immigrants face, but we
can assume that refugees and immigrants will experience
similar barriers as the ones that were mentioned in the
previous section in non-dominant populations. Specific
cultural barriers facing Arab immigrants that Inhorn and
Fakih (2006) [10] point to are: social crisis due to the in-
ability to conceive in a pronatalist society; racial discrim-
ination by a healthcare system that is predominantly
white; and men being stereotyped as hyperfertile due to
prior polygamous cultural traditions so any signs of in-
fertility are ignored. Of the Arabs that are Muslim, they
also struggle with the fact that 1) Islamic scripture disal-
lows any form of childbearing that leads to children of
unknown lineage, such as adoption or donor gametes,
and 2) a belief that infertility is God’s punishment for
prior sins. These barriers are likely not specific to Arab
American refugee/immigrants.
While this population faces the most barriers to infertil-
ity care, they are also the least studied population when it
comes to infertility care and access. A PubMed search
with the terms: “infertility care refugee,” “infertility care
immigrant,” “infertility access refugee,” and “infertility ac-
cess immigrant” yielded only four relevant papers in total
about the access to care for refugees. The three articles in-
cluded in this paper described the immigrant/refugee ex-
perience in the United States. The fourth article was not
discussed because it focuses on immigrants in a non-
United States population (Canada), which is beyond the
scope of this paper [44].
Conclusions and future directions
Though access to infertility evaluation and treatment
remains a challenge for many who face this issue, the
sub-populations of immigrants and refugees face a con-
stellation of even more adversity. Despite this, there are
similarities in assumptions of what reproductive medi-
cine can offer that transcend education and socio-
economic status (Patient Vignette 1). There are unique
opportunities to build families (Patient Vignette 2) and
also a vast number of continued challenges.
In an effort to improve access to care for non-
dominant populations, we must consider several ap-
proaches. 1) Refugees and underserved populations may
be presenting for infertility care in a variety of locations
from community doctor/nurse practitioner to a tertiary
care center. Regardless of where they present, a full his-
tory and physical exam/medical assessment is critical in
identifying any other health risks that the individual/
couple may be facing. This will allow the identification
of any potential health issues that converge on fertility
and allow for the appropriate subsequent referrals. How-
ever, these referrals must be made with the patient’s fi-
nancial and insurance status in mind. Many large
hospital complexes and academic centers may not pro-
vide adequate access to the initial evaluation for these
patients because either a) the patient does not have ac-
cess to the appropriate insurance programs or b) the
hospital does not have patient navigator services. There-
fore, there needs to be a push towards outreach and col-
laboration with the county, community, and safety net
hospitals that tend to work with this populationto ensure
that the appropriate care is acquired. In addition, pro-
viders that require health insurance or a certain level of
income should be prepared to offer alternatives for care.
Rather than turn away a patient immediately upon dis-
covering that the patient will be unable to pay, providers
should have a list on hand of centers or clinics that the
patient can try to go to for care, as well as provide them
with organizations or social workers that can help the
patient find a job and make enough money to save up
for infertility care.
2) Another important factor is the presence of transla-
tor services in hospitals and clinics. While there is an in-
creasing availability of translators, many of them may
not be educated in the lexicon of infertility (Patient Vi-
gnette 1) and therefore need to be trained and taught
the vocabulary basics of communicating not only infer-
tility evaluation and treatment modalities, but also basic
health education. Health education should not only ex-
tend to these translators however, and efforts should be
made to educate non-dominant populations. These ef-
forts are particularly important when discussing fertility
treatment, especially if treatment is determined to be
futile or has a poor prognosis. Patients must be coun-
seled in all of the risks, benefits, and anticipated suc-
cess of the treatment options. However, once the
patients are fully aware of their situation, it is also im-
portant to respect their autonomy and treat them
should they choose to receive a treatment despite futil-
ity or poor prognosis as recommended by the Ethics
Committee for the ASRM [45].
3) Specific steps that can be taken to improve care for
refugees include interdisciplinary care and collaborations
between hospitals and refugee support systems. There is
evidence that an interdisciplinary setting is more benefi-
cial and increases access to care for refugees [46], and it
is a model that needs to be further tested and imple-
mented. At present, as part of the application for asy-
lum, a refugee meets with a primary care physician/
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refugee service for a medical examination. That evalu-
ation and point of care represents the first opportunity
for identifying hardships and diagnosing chronic
illnesses that a refugee could have. In cases of chronic
illnesses that can cause infertility, this group must be
made aware of the long term implications of leaving the
illnesses untreated. Working with the communities that
provide support for refugees has helped in the treatment
of mental health issues [47] and should be considered as
a strategy for early assessment of infertility risk.
4) Lastly and perhaps most importantly, culturally
competent care towards refugees/immigrants and non-
dominant populations is very necessary. One belief that
converges on reproduction is that individuals or couples
who are socially and economically disadvantaged do not
deserve the right of access to infertility care. We must
challenge this notion to better understand our individual
and institutional aspects of racism. Changing this belief
and expanding compassion to understand and work with
extenuating circumstances that are unique to each indi-
vidual patient is at the root of improving access to care.
In particular, schools have begun to teach health profes-
sions students about cultural competency and the
unique issues that face refugees [48]. However, more
needs to be done in clinician education to include cul-
tural competence, compassion, and understanding for
the problems, wants, and needs of these deserving but
underserved populations. If the status quo in healthcare
can be changed and improved upon, infertility treat-
ments will also present an opportunity to rebuild the
decimated refugee populations.
In conclusion, we have utilized case presentations and
literature review and propose some considerations for
the approach to improving access to infertility care in
vulnerable populations which have been summarized in
the highlights section (Additional file 1). Despite the
numerous challenges that face under-represented popu-
lations (finances, education, lack of time, cultural per-
ceptions, comorbid health issues), it is important for
providers working with this population to try their best to
provide infertility care. This is particularly important not
just in infertility care but also in care for these patients in
all health settings. As we try to implement changes in
healthcare to accommodate this population, we can hope
to provide opportunities for success in creating a family.
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